selected publications
-
academic article
- Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. 2009
- Long-term control of neuropathic pain in a non-viral gene therapy paradigm.. Gene therapy. 16:470-475. 2009
- Glia in pathological pain: a role for fractalkine.. Journal of neuroimmunology. 198:113-120. 2008
- Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. 2006
- Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain.. Pain. 126:294-308. 2006